SCHEMBL19738514

SCHEMBL19738514

c1ccc(-c2ccc(Nc3cc(-c4ccccc4)cc(N(c4ccccc4)c4ccc(-c5ccccc5)cc4)c3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.39
▸ L3MBTL1 Q9Y468 4/20 0.39
▸ HSD17B10 Q99714 3/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ ALOX12 P18054 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ SLC6A2 P23975 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ MAPT P10636 3/20 0.37
▸ CYP3A4 P08684 3/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ MMP2 P08253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30574576 0.97 HSD17B10 (0.40) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12
SCHEMBL24531260 0.97 HSD17B10 (0.40) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12
SCHEMBL19738501 0.95 HSD17B10 (0.41) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12
SCHEMBL30574593 0.95 HSD17B10 (0.41) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12
SCHEMBL19738488 0.93 HSD17B10 (0.43) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12
SCHEMBL21234651 0.91 ALDH1A1 (0.43) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12
SCHEMBL23620649 0.91 ALDH1A1 (0.43) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12
SCHEMBL21234541 0.90 ALDH1A1 (0.47) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12
SCHEMBL28303200 0.90 ALDH1A1 (0.44) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12
SCHEMBL21234501 0.88 ALDH1A1 (0.48) ALDH1A1L3MBTL1HSD17B10TDP1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11233202-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2022-01-25 — — US disclosed
US-20210226130-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-07-22 — — US disclosed
WO-2017217654-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF 덕산네오룩스 주식회사 2017-12-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210226130-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, OR10J3 ALDH1A1 666/4885L3MBTL1 915/4885HSD17B10 2360/4885
US-11233202-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, OR10J3 ALDH1A1 666/4885L3MBTL1 915/4885HSD17B10 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback